Biogen, Inc. (NQ: BIIB )

371.90 USD -2.50 (-0.67%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 23, 2021 Add to My Watchlist

Price and Volume

Volume	1,774,886
Open	376.01
Bid (Size)	372.25 (1)
Ask (Size)	374.00 (5)
Prev. Close	374.40
Today's Range	364.30 - 376.01
52wk Range	223.25 - 468.35
Shares Outstanding	150,554,750
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Eisai And Biogen Inc. Announce U.S. FDA Grants Breakthrough Therapy Designation For Lecanemab (BAN2401), An Anti-Amyloid Beta Protofibril Antibody For The Treatment Of Alzheimer's Disease

Today 16:06 EDT

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Michel Vounatsos, "Biogen") today announced that...

Kenan Fellows Program and Biogen Foundation Collaborate to Advance Workforce Education

Today 11:30 EDT

Performance

YTD	+53.08%	+53.08%
1 Month	+33.36%	+33.36%
3 Month	+39.18%	+39.18%
6 Month	+50.04%	+50.04%
1 Year	+40.72%	+40.72%

More News

June 22, 2021

Noteworthy Wednesday Option Activity: RUTH, EVBG, BIIB

Today 15:30 EDT

Biogen Stock Dips As FDA Documents Outline Internal Strife Ahead Of Alzheimer's OK

Today 13:48 EDT

Pfizer argues its case in federal court for helping seniors meet drug copays

Today 11:16 EDT

Netflix And Amazon Lead The Nasdaq Higher Tuesday

June 22, 2021

Noteworthy ETF Outflows: XBI, BIIB, NTLA, CDNA

June 21, 2021

FDA approved Biogen Alzheimer’s drug despite some objections by staff

June 22, 2021

What Happened to Sage Therapeutics Stock?

June 21, 2021

Why Biogen Isn't a Buy After Its Alzheimer's Drug Approval

June 20, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.